Location History:
- Lund, SE (2019)
- Heidelberg, DE (2019)
Company Filing History:
2 out of 1,778 
2 out of 9 Years Active: 2019
Title: Katja Hess: Innovator in Stem Cell Research
Introduction
Katja Hess is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of stem cell research, particularly in the differentiation of pluripotent stem cells. Her innovative approaches have led to the development of methods that hold promise for regenerative medicine.
Latest Patents
Katja Hess holds 2 patents that focus on advancing stem cell technology. Her latest patents include:
1. **Efficient induction of definitive endoderm from pluripotent stem cells** - This invention relates to a method for differentiating pluripotent stem cells into a primitive streak cell population, which can further mature into definitive endoderm.
2. **Generation of pancreatic endoderm from pluripotent stem cells using small molecules** - This method produces pancreatic cells or pancreatic cell precursors that express at least 5% PDX1/NKX6.1 double positive. It involves exposing definitive endoderm cells to an effective amount of one or more small molecules to facilitate differentiation into pancreatic cells or precursors.
Career Highlights
Throughout her career, Katja has worked with notable companies such as Novo Nordisk A/S and Takara Bio Europe AB. Her work in these organizations has allowed her to apply her research in practical settings, contributing to advancements in biotechnology and medicine.
Collaborations
Katja has collaborated with esteemed colleagues, including Nina Funa and Jenny Ekberg. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Katja Hess is a trailblazer in the field of stem cell research, with a focus on developing methods for cell differentiation. Her patents and collaborations reflect her commitment to advancing medical science and improving therapeutic options.